Emerging data suggest Retatru tide , a dual activator targeting both the gut-brain axis and another hormone, could offer a promising development for body loss . Initial human investigations have demonstrated substantial decreases in abdominal tissue, conceivably outperforming existing weight-loss therapies . However , additional assessment is neede